Long COVID: Potential Risk Factors Identified via Analysis of Documented Care
Researchers evaluated patients with documented care for long COVID to determine factors associated with its occurrence.
Researchers evaluated patients with documented care for long COVID to determine factors associated with its occurrence.
Researchers conducted a study to determine whether treatment with sotrovimab decreases the risk for severe disease progression among high-risk patients with mild-to-moderate COVID-19.
Researchers conducted a study to determine whether molecular biomarkers of tubular injury measured on hospital admission are a significant predictor of acute kidney injury in patients with SARS-CoV-2 infection.
Investigators evaluated resistance to fluoroquinolones, nitrofurantoin, and trimethoprim-sulfamethoxazole in patients with uncomplicated urinary tract infection.
Investigators determined whether ABO and Rh blood groups were associated with risk for SARS-CoV-2 infection and severe COVID-19 illness.
Study authors provided a systemic analysis of to identify key characteristics of extensive and advanced COVID-19.